[Hepatic involvement in HIV 1 virus infection]

Area of Science:

• Hepatology
• Infectious Diseases
• Immunology

Context:

• Human Immunodeficiency Virus type 1 (HIV-1) infection is associated with various opportunistic infections and comorbidities.
• Liver injury is a significant concern in HIV-1 patients, potentially influenced by co-infections like Hepatitis B virus (HBV).
• Understanding the spectrum of liver abnormalities and their correlation with disease progression and immune status is crucial for patient management.

Purpose:

• To evaluate the prevalence and types of liver injury in HIV-1 infected patients.
• To assess the correlation between liver abnormalities, clinical staging (CDC classification), and T4 lymphocyte counts.
• To determine the prevalence of HBV infection markers and their association with clinical and immunological parameters in HIV-1 patients.

Summary:

• One hundred HIV-1 patients were assessed for liver injury; 60% exhibited elevated transaminases or Gamma-Glutamyl Transferase (GGT).
• Hepatitis B virus (HBV) infection markers were highly prevalent (29%), with a potential HBV variant suggested by monoclonal antibody detection.
• Liver histology in 32 patients revealed minimal active disease (16%), and elevated liver enzymes correlated with lower T4 lymphocyte counts (<200/ml).

Impact:

• This research highlights the high burden of liver abnormalities and HBV co-infection in HIV-1 patients.
• Findings suggest that liver enzyme elevations in HIV-1 patients may serve as indicators of immune suppression.
• The study underscores the importance of monitoring liver health and HBV status in the management of HIV-1 infection.